GenFlat Holdings, Inc. 8-K

What Happened
GenFlat Holdings, Inc. (GFLT) filed an 8-K on December 30, 2025 disclosing amended and restated employment agreements for President Garrett R. Hall and for incoming Chief Commercial Officer Matthew J. Albanese and Chief Financial Officer William R. Benz. The agreements take effect upon completion of the company’s anticipated public offering (Form S-1 initially filed November 21, 2025). Each executive will receive increased base pay or sign-on compensation, eligibility for annual cash bonuses, equity awards, participation in company benefit plans, and severance protections.

Key Details

• Garrett R. Hall (President): base salary $150,000 currently, increases to $275,000 after the Public Offering; eligible for an annual cash bonus up to $137,500; 3% commission on certain sales/lease revenue; granted 330,000 restricted stock units (RSUs) that vest on February 28, 2026; six months’ severance if terminated without Cause or if he leaves for Good Reason.
• Matthew J. Albanese (Chief Commercial Officer): appointment effective upon the Public Offering; base salary $275,000; eligible for annual bonus up to $137,500; 3% commission on certain sales/lease revenue; sign‑on grant of 330,000 RSUs vesting February 28, 2026; six months’ severance.
• William R. Benz (Chief Financial Officer): appointment effective upon the Public Offering; base salary $275,000; eligible for annual bonus up to $137,500; sign‑on grant of 100,000 stock options (50,000 vest on grant date, then 25,000 vest each anniversary); six months’ severance.
• All three may participate in the Company’s employee benefit plans. The agreements reference change‑in‑control benefits under the company’s Restated 2020 Equity Incentive Plan.

Why It Matters
These contracts formalize post‑IPO compensation, equity and severance terms for three senior executives, which will affect executive compensation expense and create potential equity dilution from RSUs and options once the Public Offering is completed. Investors should note the timing (effective upon the anticipated Public Offering) and the measurable items: higher base salaries, sizable equity grants (two 330,000 RSU awards and a 100,000‑option award), bonus caps, commission arrangements, and six‑month severance protections.